Order Article Reprints

Dalmasso C, Pagès C, Chaltiel L, Sibaud V, Moyal E, Chira C, Sol JC, Latorzeff I, Meyer N, Modesto A. Intracranial Treatment in Melanoma Patients with Brain Metastasis Is Associated with Improved Survival in the Era of Immunotherapy and Anti-BRAF Therapy. Cancers. 2021; 13(17):4493. https://doi.org/10.3390/cancers13174493

Dalmasso, Céline, Cécile Pagès, Léonor Chaltiel, Vincent Sibaud, Elisabeth Moyal, Ciprian Chira, Jean Christophe Sol, Igor Latorzeff, Nicolas Meyer, and Anouchka Modesto. 2021. "Intracranial Treatment in Melanoma Patients with Brain Metastasis Is Associated with Improved Survival in the Era of Immunotherapy and Anti-BRAF Therapy" Cancers 13, no. 17: 4493. https://doi.org/10.3390/cancers13174493

Dalmasso, C., Pagès, C., Chaltiel, L., Sibaud, V., Moyal, E., Chira, C., Sol, J. C., Latorzeff, I., Meyer, N., & Modesto, A. (2021). Intracranial Treatment in Melanoma Patients with Brain Metastasis Is Associated with Improved Survival in the Era of Immunotherapy and Anti-BRAF Therapy. Cancers, 13(17), 4493. https://doi.org/10.3390/cancers13174493